港股異動 | 金山軟件漲逾5% 金山雲在美遞交IPO
格隆匯4月20日丨金山軟件(3888.HK)現報27.85港元,漲5.29%,暫成交1.8億港元,最新總市值382億港元。雷軍旗下雲服務商金山雲正式向美國證券交易委員會(SEC)遞交IPO申請書,擬在納斯達克交易所上市,代碼為“KC”,計劃募集至多1億美元資金。此次金山雲IPO承銷商包括摩根大通、UBS、瑞士信貸和CICC。據金山雲IPO文件顯示,金山軟件在此次發行前持有約14.07億股,佔總股本的53.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.